OTHER × Colorectal Neoplasms × Neoadjuvant Therapy × Clear all ARETHUSA
Phase 2 Completed
107 enrolled 14 charts
PICC
Phase 2 Recruiting
270 enrolled
COLLISION RELAPSE Trial
Phase 3 Recruiting
360 enrolled
HIPEC
Phase 2 Unknown
140 enrolled
3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases
Unknown
120 enrolled
Envafolimab as Neoadjuvant Immuntherapy in Resectable Local Advanced dMMR/MSI-H Colorectal Cancer
Phase 2 Unknown
26 enrolled
An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC)
Phase 2 Unknown
100 enrolled
Chemotherapy for Resectable Colorectal Liver Metastases
Completed
967 enrolled
Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer
Phase 3 Completed
598 enrolled
NACSOC
Phase NA Unknown
248 enrolled
Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis
Phase 3 Recruiting
688 enrolled
Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery
Phase 2 Terminated
19 enrolled
IRAM
Phase 2 Withdrawn
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
Phase 2 Completed
90 enrolled 10 charts
Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma
Phase 2 Terminated
5 enrolled 6 charts
Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer
Phase 2 Withdrawn
COPERNICUS
Phase 2 Completed
60 enrolled
CARCINOSIS
Phase 2 Unknown
30 enrolled
PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery
Phase NA Completed
149 enrolled
Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal Cancer
Phase NA Completed
28 enrolled
GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer
Phase 2 Completed
50 enrolled
Monoclonal Antibody Therapy in Treating Patients With Colorectal Cancer
Phase 1 Completed
12 enrolled
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery
Phase 1 Withdrawn
Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum
Phase 1/2 Completed
37 enrolled
Celecoxib in Treating Patients With Early-Stage Rectal Cancer
Phase NA Terminated
10 enrolled
Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer
Phase 3 Unknown
340 enrolled
Neo-adjuvant Therapy and the Effect on Synchronous Metastatic Growth
Phase 2 Unknown
60 enrolled
FOGT5
Phase 2 Completed
168 enrolled
Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer
Phase 1 Completed
EXPERT-C
Phase 2 Unknown
164 enrolled
Phase 3 Study of Surgery Combined With Neoadjuvant Chemotherapy(XELOX) in Colorectal Cancer With Resectable Liver Metastasis
Phase 3 Unknown
392 enrolled